NYSE:ITGR

Integer (ITGR) Stock Forecast, Price & News

$77.92

-0.51 (-0.65%)

(As of 01:52 PM ET)

Compare

Today's Range: $77.73
▼
$78.60
50-Day Range: $78.45
▼
$92.93
52-Week Range: $50.05
▼
$96.17

Volume: 39,859 shs
Average Volume: 278,193 shs
Market Capitalization: $2.60 billion

P/E Ratio: 36.75
Dividend Yield: N/A
Price Target: $93.83

Integer MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 19.6% Upside
$93.83 Price Target
Short Interest: Bearish
6.77% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.40
Based on 6 Articles This Week
Insider Trading: Selling Shares
$535,080 Sold Last Quarter
Proj. Earnings Growth: 15.01%
From $4.33 to $4.98 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.10 out of 5 stars

Medical Sector

517th out of 969 stocks

Electromedical Equipment Industry

13th out of 20 stocks

2.3

Analyst's Opinion

Consensus Rating
Integer has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $93.83, Integer has a forecasted upside of 19.6% from its current price of $78.48.
Amount of Analyst Coverage
Integer has only been the subject of 3 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
6.77% of the float of Integer has been sold short.
Short Interest Ratio / Days to Cover
Integer has a short interest ratio ("days to cover") of 9.6.
Change versus previous month
Short interest in Integer has recently increased by 0.91%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Integer does not currently pay a dividend.
Dividend Growth
Integer does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ITGR.

2.4

News and Social Media Coverage

News Sentiment
Integer has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Integer this week, compared to 3 articles on an average week.
MarketBeat Follows
1 people have added Integer to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Integer insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $535,080.00 in company stock.
Percentage Held by Insiders
Only 1.84% of the stock of Integer is held by insiders.
Percentage Held by Institutions
99.29% of the stock of Integer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Integer are expected to grow by 15.01% in the coming year, from $4.33 to $4.98 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Integer is 37.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 110.43.
Price to Earnings Ratio vs. Sector
The P/E ratio of Integer is 37.02, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 97.21.
Price to Earnings Growth Ratio
Integer has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Integer has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Integer (NYSE:ITGR) Stock

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

ITGR Price History

30 days | 90 days | 365 days | Advanced Chart

ITGR Stock News Headlines

September 29, 2023 | americanbankingnews.com

Integer Holdings Co. (NYSE:ITGR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

September 28, 2023 | finance.yahoo.com

Integer Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023

October 2, 2023 | Legacy Research (Ad)

Elon Did It Again: This Could be Bigger than Tesla

Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.

September 26, 2023 | americanbankingnews.com

Integer (NYSE:ITGR) versus Vaso (OTCMKTS:VASO) Head-To-Head Survey

September 25, 2023 | finance.yahoo.com

Is Integer Holdings Corporation's (NYSE:ITGR) Stock Price Struggling As A Result Of Its Mixed Financials?

September 21, 2023 | msn.com

ITGR or EW: Which Is the Better Value Stock Right Now?

September 14, 2023 | finance.yahoo.com

Director Donald Spence Sells 6,500 Shares of Integer Holdings Corp (ITGR)

September 11, 2023 | finance.yahoo.com

Reasons to Add Integer Holdings (ITGR) Stock to Your Portfolio

October 2, 2023 | Legacy Research (Ad)

Elon Did It Again: This Could be Bigger than Tesla

August 18, 2023 | finance.yahoo.com

The Zacks Analyst Blog Highlights Abcam, Integer Holdings and RxSight

August 14, 2023 | finance.yahoo.com

Integer Holdings (NYSE:ITGR) Has Some Way To Go To Become A Multi-Bagger

August 2, 2023 | msn.com

Integer Holdings (ITGR) Price Target Increased by 10.74% to 101.66

August 2, 2023 | msn.com

Integer Holdings: Revised Expectations Look Well Accounted For In Price Extension

July 29, 2023 | msn.com

Keybanc Maintains Integer Holdings (ITGR) Overweight Recommendation

July 29, 2023 | msn.com

Benchmark Maintains Integer Holdings (ITGR) Buy Recommendation

July 28, 2023 | markets.businessinsider.com

Where Integer Holdings Stands With Analysts

July 28, 2023 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Ford Motor (F), Integer Holdings (ITGR) and WW Grainger (GWW)

July 27, 2023 | finance.yahoo.com

Compared to Estimates, Integer (ITGR) Q2 Earnings: A Look at Key Metrics

July 27, 2023 | msn.com

Integer (ITGR) Tops Q2 Earnings and Revenue Estimates

July 27, 2023 | finance.yahoo.com

Integer Holdings Corporation Reports Second Quarter 2023 Results

July 26, 2023 | markets.businessinsider.com

What Wall Street expects from Integer's earnings

July 3, 2023 | finance.yahoo.com

Integer Holdings (ITGR) Hits 52-Week High: What's Aiding It?

June 29, 2023 | finance.yahoo.com

Integer Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023

June 15, 2023 | finance.yahoo.com

Integer to Participate in Citi's 2023 European Healthcare Conference

May 16, 2023 | msn.com

ITGR vs. EW: Which Stock Is the Better Value Option?

May 13, 2023 | finance.yahoo.com

Despite lower earnings than five years ago, Integer Holdings (NYSE:ITGR) investors are up 17% since then

May 13, 2023 | msn.com

Integer Holdings Stock: The Risk-Reward Is Not On Your Side

See More Headlines

Receive ITGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.

ITGR Company Calendar

Last Earnings: 7/27/2023
Today: 10/02/2023
Next Earnings (Confirmed): 10/26/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Electromedical equipment
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:ITGR
Previous Symbol: NASDAQ:ITGR
CUSIP: 39153L10
CIK: 1114483
Web: www.integer.net
Phone: (214) 618-5243
Fax: 716-759-5654
Employees: 10,000
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $93.83
High Stock Price Forecast: $105.00
Low Stock Price Forecast: $85.00
Forecasted Upside/Downside: +19.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): $2.12
Trailing P/E Ratio: 37.00
Forward P/E Ratio: 18.11
P/E Growth: 1.49
Net Income: $66.38 million
Net Margins: 4.77%
Pretax Margin: 5.59%
Return on Equity: 9.67%
Return on Assets: 4.84%

Debt

Debt-to-Equity Ratio: 0.68
Current Ratio: 3.08
Quick Ratio: 1.94

Sales & Book Value

Annual Sales: $1.38 billion
Price / Sales: 1.90
Cash Flow: $6.75 per share
Price / Cash Flow: 11.62
Book Value: $42.78 per share
Price / Book: 1.83

Miscellaneous

Outstanding Shares: 33,310,000
Free Float: 32,695,000
Market Cap: $2.61 billion
Optionable: Optionable
Beta: 1.11

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Joseph W. Dziedzic (Age 55)
Pres, CEO & Director
Comp: $2M

Ms. Jennifer M. Bolt (Age 54)
Exec. VP of Global Operations & ESG
Comp: $598.63k

Mr. Payman Khales (Age 53)
Pres of Cardio & Vascular
Comp: $652.92k

Mr. Diron Smith (Age 50)
VP of Financial Planning & Analysis and Interim CFO

Mr. Tom P. Thomas (Age 52)
VP, Corp. Controller & Principal Accounting Officer

Mr. Andrew Senn (Age 41)
Sr. VP of Strategy, Bus. Devel. & Investor Relations

Mr. McAlister C. Marshall II (Age 53)
Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec.

Mr. Kirk K. Thor (Age 59)
Exec. VP & Chief HR Officer

Ms. Margaret Carthy (Age 59)
Sr. VP of Global Quality & Regulatory Affairs

Mr. Jim Stephens
Pres of Cardiac Rhythm Management & Neuromodulation

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ITGR Stock - Frequently Asked Questions

Should I buy or sell Integer stock right now?: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ITGR shares.
View ITGR analyst ratings or view top-rated stocks.
What is Integer's stock price forecast for 2023?: 6 analysts have issued twelve-month target prices for Integer's shares. Their ITGR share price forecasts range from $85.00 to $105.00. On average, they expect the company's share price to reach $93.83 in the next year. This suggests a possible upside of 19.6% from the stock's current price.
View analysts price targets for ITGR or view top-rated stocks among Wall Street analysts.
How have ITGR shares performed in 2023?: Integer's stock was trading at $68.46 on January 1st, 2023. Since then, ITGR shares have increased by 14.6% and is now trading at $78.43.
View the best growth stocks for 2023 here.
When is Integer's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our ITGR earnings forecast.
How can I listen to Integer's earnings call?: Integer will be holding an earnings conference call on Thursday, October 26th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 647-362-9199 with passcode "9252310".
How were Integer's earnings last quarter?: Integer Holdings Co. (NYSE:ITGR) released its earnings results on Thursday, July, 27th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts' consensus estimates of $0.99 by $0.15. The medical equipment provider earned $400.04 million during the quarter, compared to analyst estimates of $367.05 million. Integer had a trailing twelve-month return on equity of 9.67% and a net margin of 4.77%.
What ETFs hold Integer's stock?: ETFs with the largest weight of Integer (NYSE:ITGR) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), SPDR S&P 600 Small CapValue ETF (SLYV), iShares S&P Small-Cap 600 Value ETF (IJS), Vanguard S&P Small-Cap 600 Value ETF (VIOV), Xtrackers S&P SmallCap 600 ESG ETF (SMLE) and SPDR S&P 600 Small Cap ETF (SLY).iShares U.S. Medical Devices ETF (IHI).
What guidance has Integer issued on next quarter's earnings?: Integer updated its FY 2023 earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $4.23-$4.42 for the period, compared to the consensus EPS estimate of $4.15. The company issued revenue guidance of $1.53 billion-$1.55 billion, compared to the consensus revenue estimate of $1.50 billion.

What is Joseph Dziedzic's approval rating as Integer's CEO?: 40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.
What other stocks do shareholders of Integer own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).
What is Integer's stock symbol?: Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."
How do I buy shares of Integer?: Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Integer's stock price today?: One share of ITGR stock can currently be purchased for approximately $78.43.
How much money does Integer make?: Integer (NYSE:ITGR) has a market capitalization of $2.61 billion and generates $1.38 billion in revenue each year. The medical equipment provider earns $66.38 million in net income (profit) each year or $2.12 on an earnings per share basis.
How many employees does Integer have?: The company employs 10,000 workers across the globe.
How can I contact Integer?: Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The official website for the company is www.integer.net. The medical equipment provider can be reached via phone at (214) 618-5243, via email at ir@integer.net, or via fax at 716-759-5654.

This page (NYSE:ITGR) was last updated on 10/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial